Picture of 2cureX AB logo

2CUREX 2cureX AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: 2cureX: Inditreat Selected To Multinational Ovarian Cancer Project

Feb 4 (Reuters) - 2cureX AB  2CUREX.ST :
    * INDITREAT® SELECTED TO PRESTIGIOUS MULTINATIONAL OVARIAN
CANCER
PROJECT.
    * 2CUREX WILL PROVIDE FUNCTIONAL PRECISION TESTING WITHIN A
PRESTIGIOUS MULTINATIONAL OVARIAN CANCER PROJECT, DECIDER, WHICH
HAS BEEN GRANTED 15 MEUR FROM EU

Source text for Eikon:  ID:nWkr2Yr5qf 
Further company coverage:  2CUREX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on 2cureX AB

See all news